Directing Neuronal Signaling through Cell-Surface Glycan Engineering by Pulsipher, Abigail et al.
Directing Neuronal Signaling through Cell-Surface Glycan
Engineering
Abigail Pulsipher,† Matthew E. Griffin,† Shannon E. Stone,† Joshua M. Brown,†
and Linda C. Hsieh-Wilson*,†
†Division of Chemistry and Chemical Engineering, California Institute of Technology and Howard Hughes Medical Institute, 1200
East California Boulevard, Pasadena, California 91125, United States
*S Supporting Information
ABSTRACT: The ability to tailor plasma membranes
with specific glycans may enable the control of signaling
events that are critical for proper development and
function. We report a method to modify cell surfaces
with specific sulfated chondroitin sulfate (CS) glycosami-
noglycans using chemically modified liposomes. Neurons
engineered to display CS-E-enriched polysaccharides
exhibited increased activation of neurotrophin-mediated
signaling pathways and enhanced axonal growth. This
approach provides a facile, general route to tailor cell
membranes with biologically active glycans and demon-
strates the potential to direct important cellular events
through cell-surface glycan engineering.
Glycosaminoglycans (GAGs) are sulfated, linear poly-saccharides that participate in many fundamental
physiological processes, including cell division, cancer meta-
stasis, angiogenesis, and neuronal development.1−3 Increasing
evidence suggests that GAGs interact with diverse proteins in a
sulfation-dependent manner and modulate cellular signaling
events.3a,b,4 For example, a specific sulfation motif found on
chondroitin sulfate GAGs (CS-E, Figure 1A) engages neuro-
trophin growth factors and their receptors, thereby stimulating
downstream signaling pathways to enhance neurite out-
growth.3a,4a Indeed, distinct sulfation patterns have been
shown to modulate pathways involved in development,3b,c,4c
normal physiological function,4a,b and disease.5 Thus, the ability
to present specific GAG structures on cell surfaces could
provide a novel approach to control key cellular events. Such a
method may also accelerate structure−function studies, as the
complex, heterogeneous nature of GAGs on cell surfaces has
hampered efforts to understand the roles of specific sulfation
motifs in vivo.
Although a few strategies for engineering cell-surface glycans
have been reported,6 the remodeling of cell membranes with
complex polysaccharides such as GAGs has not been
demonstrated. In addition, such strategies cannot be readily
adapted to GAGs, and application of these methodologies has
been largely limited to imaging6b−d or studying cell-surface
phenomena, such as receptor clustering.6e Here we develop a
method to display specific sulfated GAG structures on cell
surfaces using a liposomal fusion strategy. We show that
tailoring membranes with the CS-E structure activates growth
factor-mediated signaling pathways and enables the fine-tuned
modulation of neuronal growth. These findings demonstrate
that chemically controlling the presentation of exogenous
glycans on cell surfaces can induce sustained effects on cellular
signaling and function. Our studies also highlight the potential
for glycan engineering to modulate complex cellular events, and
they provide a powerful, new tool for remodeling cell
membranes with a wide variety of important biomolecules.
We chose to utilize liposomes as glycan carriers due to their
biocompatibility, ease of preparation, low cytotoxicity, and
tunable biophysical properties.7 Elegant studies have used
glycan-presenting vesicles for intracellular antigen delivery8 or
sugar-encapsulated vesicles with folate receptors for cell-specific
metabolic labeling.6d However, only two liposomal methods
have been developed to our knowledge for the cell-surface
display of exogenous molecules, namely fluorophores.9 We
expanded on these methods in an effort to incorporate large,
sulfated GAGs into cell membranes (Figure 1B). To promote
membrane fusion and surface presentation of the glycans rather
than intracellular uptake, we used cationic 1,2-dioleoyl-3-
trimethylammonium-propane chloride (DOTAP) and neutral
1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine (DOPE) as
our primary lipids. Phosphatidylethanolamine lipids are an
abundant, natural component of the neuronal cell membrane,
and DOPE-based liposomes containing a lipid-functionalized
fluorophore have been used to label a variety of cell types,
including primary neurons.9b Here we also incorporated 2-
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Figure 1. (A) CS polysaccharide structures used in this study. n ≈ 110.
(B) Strategy to remodel cell surfaces with CS GAGs and control
signaling pathways.
Communication
pubs.acs.org/JACS
© 2014 American Chemical Society 6794 dx.doi.org/10.1021/ja5005174 | J. Am. Chem. Soc. 2014, 136, 6794−6797
Terms of Use
dodecanone into the liposomes to add a ketone handle for
appending the glycans via oxime chemistry.
CS polysaccharides containing a peptide fragment with an N-
terminal amine were readily derivatized with an aminooxy
group by coupling them to phthaloyl-protected aminooxyacetic
acid, followed by cleavage of the phthaloyl group with
hydrazine monohydrate (Scheme S1). The polysaccharides
were then incubated with dodecanone-containing liposomes at
25 °C for 3 h to produce GAG-displaying vesicles. The
synthetic ease and versatility of this approach represent
advantages compared to existing methods, which require the
radical-mediated synthesis of polymers end-functionalized with
lipids and glycans with derivatizable reducing ends.6e,f With our
approach, the lipid reagents are commercially available, and
many biomolecules can be derivatized with aminooxy groups,
including various glycans, peptides, lipids, nucleic acids, and
proteins,10 thus providing a general strategy for displaying a
diverse range of bioactive molecules.
Preliminary optimization of liposomal membrane fusion was
performed on rat pheochromocytoma (PC12) cells using
liposomes functionalized with a hydrazide-conjugated fluoro-
phore (AF488-hyd). We found that a 2:1 ratio of
DOPE:DOTAP was optimal for membrane fusion, as visualized
by fluorescence microscopy (Figure S1). To approximate the
relative levels of fluorophore incorporation at the cell surface,
we incubated liposomes containing varying concentrations of
AF488-hyd with PC12 cells on ice for 30 min. Cells labeled
with liposomes containing 10 mol % AF488-hyd displayed
similar fluorescence signal profiles by fluorescence-assisted cell
sorting (FACS) analysis as cells labeled with an anti-CS-E
monoclonal antibody4d that detected endogenous CS-E levels
(Figure 2A). These results suggest that this liposomal strategy
can incorporate exogenous molecules into cell membranes at
levels roughly similar to those of endogenous CS poly-
saccharides.
We next examined whether this approach could be used to
display large GAG polysaccharides on cell surfaces. Liposomes
containing 2:1 DOPE:DOTAP and 10% w/w dodecanone were
functionalized with CS-E-enriched polysaccharides (∼70 kDa).
To characterize their biophysical properties, we used trans-
mission electron microscopy (TEM), dynamic light scattering
(DLS), and zeta potential measurements. The liposomes
exhibited parameters predicted to favor membrane fusion,
including spherical morphologies, average diameters ranging
between 132.6 and 159.6 nm, and good stabilities (zeta
potentials of ±46−69 mV; Figure S2). The change from
positive to negative electrokinetic potential (69 to −46 mV;
Figure S2C) confirmed successful conjugation of the sulfated
polysaccharides. Furthermore, energy dispersive spectroscopy
(EDS) verified the presence of sulfur on CS-functionalized
liposomes after CS conjugation (Figure S2D). To test for
membrane fusion, PC12 cells were treated with chondroitinase
to remove endogenous CS, incubated with CS-E-modified
liposomes, and immunostained with an anti-CS-E antibody.
Importantly, strong immunostaining for CS-E was observed on
the surfaces of cells treated with CS-E-functionalized liposomes
compared to chondroitinase-treated cells without liposome
addition, indicating efficient incorporation of the polysacchar-
ides (Figure 2B).
Having validated the method, we investigated whether the
approach could be used to control cellular signaling pathways.
Previous studies from our laboratory have demonstrated that
CS-E polysaccharides can recruit nerve growth factor (NGF) to
the cell surface and promote the assembly of NGF-tropomyosin
receptor kinase (Trk) complexes.4a Complex formation, in turn,
activates protein kinase B (Akt) and phosphatidylinositol 3-
kinase (PI3K) signaling pathways and thereby enhances neurite
outgrowth.11 Thus, we reasoned that cell-surface presentation
of exogenous CS-E polysaccharides might recruit NGF to the
membrane and assist in the formation of activated signaling
complexes to induce these biological responses. Embryonic day
18 (E18) rat cortical neurons were cultured for 7 days and then
treated with liposomes displaying CS-E- or CS-C-enriched
polysaccharides (30 min, 37 °C). Neurons were stimulated with
the neurotrophin NGF for 0, 10, 30, or 60 min, and Akt
activation was monitored using a phospho-Ser473 Akt
antibody. Remarkably, neurons remodeled with CS-E poly-
saccharides showed approximately a 3-fold increase in Akt
activation relative to untreated neurons at each time point
(Figure 3), consistent with increased recruitment of NGF to
the cell surface and robust activation of Trk receptors. In
contrast, neurons remodeled with CS-C polysaccharides
showed phospho-Akt levels similar to those of untreated
neurons. These results support the importance of the CS-E
motif in NGF-stimulated Trk activation.4a Moreover, they show
that liposomal-mediated presentation of specific, sulfated CS
polysaccharides on cell surfaces can activate important neuronal
signaling pathways.
We next examined whether the exogenous CS-E-mediated
activation of Trk pathways could direct neuronal growth. Rat
E18 hippocampal neurons were cultured for 2 days and
subsequently treated for 30 min with liposomes prefunction-
alized with CS-A-, CS-C-, or CS-E-enriched polysaccharides.
Neurons were then incubated in media lacking liposomes for an
additional 24 h and immunostained with an anti-α-tubulin
antibody to image the processes using confocal fluorescence
microscopy. Initial studies revealed no appreciable difference in
neurite outgrowth between neurons displaying the different
sulfation motifs. We postulated that the membrane lifetime of
the exogenous CS GAGs might be too short to elicit functional
responses such as neurite outgrowth, which requires de novo
protein and lipid biosynthesis. Therefore, we assayed the
Figure 2. Controlled cell-surface display of CS polysaccharides and
fluorophores. (A) FACS analysis of PC12 cells treated with liposomes
presenting varying amounts (0−20%) of AF488-hyd. (B) Immuno-
fluorescence detection of CS-E (green) on PC12 cells treated with or
without chondroitinase (ChABC) and CS-E-functionalized liposomes
as indicated.
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membrane lifetime of the exogenous lipids by treating PC12
cells with liposomes bearing fluorophore-conjugated CS-E
polysaccharides and monitoring the fluorescence signal over 24
h (Figure S3). A decrease in signal was observed within 6 h, and
loss of the signal progressed over the course of 10 h. After 16 h,
weak fluorescence was detected around the cell periphery,
suggesting that the CS-conjugated lipids had been internalized
or had diffused into the medium.
To circumvent this problem, we repeated the outgrowth
assays with multiple additions of liposomes every 8 h over a 24-
h period. Under these conditions, we found that cell-surface
presentation of CS-E polysaccharides significantly enhanced
neurite outgrowth by 36.3 ± 3.3% relative to untreated neurons
(Figures 4 and S4, 10% dodecanone). As expected, neurons
displaying CS-A or CS-C polysaccharides showed minimal
neurite outgrowth when compared to untreated neurons (10.8
± 4.8% and 1.3 ± 1.8%, respectively). As a further control,
dodecanone-containing liposomes were reacted with CS-E
polysaccharides lacking the aminooxy functionality and then
incubated with the cells. No difference in neurite outgrowth
was observed relative to untreated neurons.
Remarkably, the extent of neurite outgrowth could be finely
tuned by controlling the concentration of CS-E polysaccharides
at the cell surface. Liposomes containing 0% to 10%
dodecanone were conjugated with aminooxy-functionalized
CS-E and then incubated with E18 rat hippocampal neurons as
above. Notably, we observed a dose-dependent increase in
neurite outgrowth from 4.0% to 36.3% as the dodecanone
concentration was increased from 2.5% to 10% (Figures 4B and
S4). Together, these studies demonstrate that this approach for
engineering glycans on cell surfaces can be used to finely
modulate both the signaling and functional responses of
neurons.
In conclusion, we have developed a powerful, synthetically
facile method to display large, complex CS polysaccharides on
cell surfaces using chemically modified liposomes. The surface
density, as well as the specific glycan structure, can be precisely
controlled to activate key intracellular signaling pathways and
induce functional responses in a dose-dependent manner. We
show that the presentation of CS polysaccharides enriched in a
specific sulfation motif can trigger Akt signaling pathways and
exert sustained effects on neuronal growth. In the future, we
envision that this general strategy can be extended to perform
comparative analyses of the effects of various glycans on cellular
signaling and function. Moreover, the use of targeted liposomal
delivery strategies both in vitro and in vivo will expand
application of this approach to many important biological
contexts, such as neurodegeneration, stem cell differentiation,
and cancer.
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